azacitidine,venetoclax,pivekimab sunirine
abbvie,roche,immunogen
['leukemia', 'venetoclax', 'myeloid', 'pivekimab', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'azacitidine,(-oral azaci),(-azacitidine oral)', 'leusm']
pivekimab sunirine plus azacitidine and venetoclax has demonstrated activity in patients with relapsed/refractory or newly diagnosed acute myeloid leukemia. #ash22 #leusm #aml 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.